Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a bleeding stopper boost skin spot treatment?

NCT ID NCT07401277

First seen Feb 11, 2026 · Last updated Jun 19, 2026 · Updated 16 times

Summary

This early study tests whether adding aluminum chloride, a drug that stops bleeding, to a standard 5-fluorouracil cream works better for treating actinic keratoses—rough, scaly spots from sun exposure that can turn into skin cancer. Thirty-two adults with these spots on their scalp or forearms will apply either the standard cream or the combination cream for one week. Doctors will count the spots and check skin redness before treatment, right after, and again eight weeks later to see if the combination helps clear more spots.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • West Virginia University

    RECRUITING

    Morgantown, West Virginia, 26505, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

5% 5-fluorouracil cream with or without 15% aluminum chloride hexahydrate

What this could lead to

If it works, this could lead to a more effective topical treatment for actinic keratoses, reducing the risk of skin cancer development.

What could go wrong

This is a very early Phase 1 study with only 32 people, so results may not apply to everyone. Adding aluminum chloride could also cause more skin irritation or side effects.

Conditions

The condition(s) this trial relates to.

actinic keratosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.